Azelis Group (AZE) Q3 2025 TU earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 TU earnings summary
23 Oct, 2025Executive summary
Market conditions in the first nine months of 2025 were volatile, with normalization delays from geopolitical and trade dynamics.
Free cash flow increased by 34.3% to €293.2m, reflecting strong working capital management and an asset-light business model.
Cost-saving initiatives are ahead of schedule and ramping up, with significant progress in right-sizing the organization.
Four strategic acquisitions were completed, contributing over €110m in prior-year revenue.
Group CFO Thijs Bakker will depart after nearly a decade, with a successor to be announced.
Financial highlights
Revenue for 9M 2025 was €3.2bn, up 2.1% year-on-year at constant currency, with 2.7% growth from acquisitions offsetting a 0.6% organic decline and a 3.0% FX headwind.
Gross profit was €751.9m (23.7% margin), down 1.3% year-on-year at constant currency, with margin contracting by 80 bp.
Adjusted EBITA was €332.6m (10.5% margin), down 9.9% year-on-year, with margin contraction due to slower revenue and partial cost-saving benefits.
Free cash flow conversion ratio expanded to 87.1%, up 29 percentage points year-on-year.
Leverage increased to 3.4x, influenced by slower EBITDA growth, M&A investments, and deferred payments.
Outlook and guidance
Near-term uncertainty from geopolitical and trade issues continues to weigh on demand.
Cost and working capital controls remain a focus to navigate short-term challenges.
Long-term industry fundamentals remain compelling, with continued investment in innovation and digital capabilities.
No major M&A deals expected until leverage returns below 3x; pipeline remains strong.
Positioned to capture growth as market conditions improve, but near-term visibility remains limited.
Latest events from Azelis Group
- Revenue up 1.3% to €4.1bn, but net profit fell 40% as cash flow and leverage rose.AZE
H2 202519 Feb 2026 - Stable revenue, margin gains, and acquisitions amid profit and cash flow pressure.AZE
H1 20242 Feb 2026 - Q3 2024 saw organic growth and margin gains, with acquisitions driving resilient performance.AZE
Q3 2024 TU18 Jan 2026 - Revenue and margins improved in 2024, with strong M&A activity and positive outlook for 2025.AZE
H2 202425 Dec 2025 - Revenue up 4.5% to EUR 1.1bn, but margin pressure led to cost-saving measures.AZE
Q1 2025 TU29 Nov 2025 - Revenue up 0.6% to €2.2bn, profit down 14.6%, but cash flow and acquisitions boost outlook.AZE
H1 202516 Nov 2025 - Azelis drives growth and innovation in specialty chemicals distribution with strong financial returns.AZE
Investor Lab Tour 2024 Istanbul Presentation13 Jun 2025